Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1507207rdf:typepubmed:Citationlld:pubmed
pubmed-article:1507207lifeskim:mentionsumls-concept:C0003392lld:lifeskim
pubmed-article:1507207lifeskim:mentionsumls-concept:C1095909lld:lifeskim
pubmed-article:1507207lifeskim:mentionsumls-concept:C1512977lld:lifeskim
pubmed-article:1507207lifeskim:mentionsumls-concept:C0596402lld:lifeskim
pubmed-article:1507207lifeskim:mentionsumls-concept:C0242184lld:lifeskim
pubmed-article:1507207lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:1507207lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:1507207lifeskim:mentionsumls-concept:C0068820lld:lifeskim
pubmed-article:1507207pubmed:issue17lld:pubmed
pubmed-article:1507207pubmed:dateCreated1992-9-22lld:pubmed
pubmed-article:1507207pubmed:abstractTextNitroaniline mustards have potential as hypoxia-selective cytotoxic agents, with reductive metabolism activating the nitrogen mustard by converting the electron-withdrawing nitro group to an electron-donating hydroxylamine or amine. However, the parent compounds have poor aqueous solubility, and their potencies are limited by low reduction potentials (E1/2 ca. -600 mV versus the normal hydrogen electrode) and corresponding slow rates of nitro reduction. To address these limitations, a series of 4-nitroaniline mustards bearing hydrophilic side chains attached via an electron-withdrawing carboxamide group was prepared and evaluated for hypoxia-selective cytotoxicity against Chinese hamster cell lines. The N-[(N,N-dimethylamino)ethyl]carboxamide derivatives proved to have excellent aqueous solubility and improved cytotoxic potency, but their reduction potentials, while higher than the non-carboxamide compounds, were still low and little selectivity for hypoxic cells were observed. A series of carboxamides of 2,4-dinitroaniline mustard was also prepared. These compounds had reduction potentials in the desired range (E1/2 ca. -450 mV by cyclic voltammetry) and were more toxic to hypoxic than aerobic UV4 cells. The most selective compounds were 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide (20, SN 23862) and its water-soluble N-[(N,N-dimethylamino)ethyl]carboxamide analogue. These showed selectivities of 60- to 70-fold for hypoxic UV4 cells. The selectivity of 20 was much superior to that of its aziridine analogue (23, CB 1954), which was only 3.6-fold more toxic to hypoxic than oxic cells in the same system. Compound 20 is a much less efficient substrate than CB 1954 for the major aerobic nitroreductase from rat Walker tumor cells, NAD(P)H:quinone oxidoreductase (DT diaphorase). Lack of aerobic bioactivation of 20 by DT diaphorases may be responsible for its higher hypoxic selectivity than that of 23.lld:pubmed
pubmed-article:1507207pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1507207pubmed:languageenglld:pubmed
pubmed-article:1507207pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1507207pubmed:citationSubsetIMlld:pubmed
pubmed-article:1507207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1507207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1507207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1507207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1507207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1507207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1507207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1507207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1507207pubmed:statusMEDLINElld:pubmed
pubmed-article:1507207pubmed:monthAuglld:pubmed
pubmed-article:1507207pubmed:issn0022-2623lld:pubmed
pubmed-article:1507207pubmed:authorpubmed-author:WilsonW RWRlld:pubmed
pubmed-article:1507207pubmed:authorpubmed-author:DennyW AWAlld:pubmed
pubmed-article:1507207pubmed:authorpubmed-author:PalmerB DBDlld:pubmed
pubmed-article:1507207pubmed:authorpubmed-author:CliffeSSlld:pubmed
pubmed-article:1507207pubmed:issnTypePrintlld:pubmed
pubmed-article:1507207pubmed:day21lld:pubmed
pubmed-article:1507207pubmed:volume35lld:pubmed
pubmed-article:1507207pubmed:ownerNLMlld:pubmed
pubmed-article:1507207pubmed:authorsCompleteYlld:pubmed
pubmed-article:1507207pubmed:pagination3214-22lld:pubmed
pubmed-article:1507207pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:meshHeadingpubmed-meshheading:1507207-...lld:pubmed
pubmed-article:1507207pubmed:year1992lld:pubmed
pubmed-article:1507207pubmed:articleTitleHypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells.lld:pubmed
pubmed-article:1507207pubmed:affiliationCancer Research Laboratory, University of Auckland School of Medicine, New Zealand.lld:pubmed
pubmed-article:1507207pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1507207pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1507207pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1507207pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:1507207lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1507207lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1507207lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1507207lld:pubmed